NERV
Minerva Neurosciences Inc
NASDAQ: NERV · HEALTHCARE · BIOTECHNOLOGY
$5.63
+2.14% today
Updated 2026-06-04
Market cap
$215.71M
P/E ratio
—
P/S ratio
1.87x
EPS (TTM)
$-37.03
Dividend yield
—
52W range
$2 – $9
Volume
0.2M
Minerva Neurosciences Inc (NERV) Insider transactions
Net insider activity
Net buying (9,590,318 shares)
Buy transactions
81
Sell transactions
19
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | KAUL, INDERJIT | Director | Buy | 12,169 | — | — |
| 2025-12-22 | VAN, HEEK G JAN | Director | Buy | 50,000 | — | — |
| 2025-12-22 | RACE, GEOFF | President | Buy | 1,500,000 | — | — |
| 2025-12-22 | LUTHRINGER, REMY | Director, CEO | Buy | 2,250,000 | — | — |
| 2025-12-22 | LAGHRISSI-THODE, FOUZIA | Director | Buy | 50,000 | — | — |
| 2025-12-22 | KUPFER, DAVID | Director | Buy | 50,000 | — | — |
| 2025-12-22 | KAUL, INDERJIT | Director | Buy | 364,504 | — | — |
| 2025-12-22 | HASLER, HANS PETER | Director | Buy | 50,000 | — | — |
| 2025-12-22 | AHLHOLM, FREDERICK W | SVP, CFO and Secretary | Buy | 500,000 | — | — |
| 2025-11-14 | KAUL, INDERJIT | Director | Buy | 9,500 | — | — |
| 2024-12-05 | VAN, HEEK G JAN | Director | Buy | 12,500 | — | — |
| 2024-12-05 | RACE, GEOFF | President | Buy | 95,000 | — | — |
| 2024-12-05 | LUTHRINGER, REMY | Director, CEO | Buy | 105,000 | — | — |
| 2024-12-05 | LAGHRISSI-THODE, FOUZIA | Director | Buy | 12,500 | — | — |
| 2024-12-05 | KUPFER, DAVID | Director | Buy | 12,500 | — | — |
| 2024-12-05 | HASLER, HANS PETER | Director | Buy | 12,500 | — | — |
| 2024-12-05 | AHLHOLM, FREDERICK W | SVP, CFO and Secretary | Buy | 47,500 | — | — |
| 2023-10-04 | RACE, GEOFF | President | Buy | 87,050 | — | — |
| 2023-10-04 | LUTHRINGER, REMY | Director, CEO | Buy | 100,450 | — | — |
| 2023-10-04 | AHLHOLM, FREDERICK W | SVP, CFO and Secretary | Buy | 42,850 | — | — |
| 2023-09-27 | VAN, HEEK G JAN | Director | Buy | 12,500 | — | — |
| 2023-09-27 | LAGHRISSI-THODE, FOUZIA | Director | Buy | 12,500 | — | — |
| 2023-09-27 | KUPFER, DAVID | Director | Buy | 12,500 | — | — |
| 2023-09-27 | HILLEMAN, JERYL L | Director | Buy | 12,500 | — | — |
| 2023-09-27 | HASLER, HANS PETER | Director | Buy | 12,500 | — | — |
| 2023-05-02 | LUTHRINGER, REMY | Director, CEO | Sale | 3,641 | $3.76 | $13690.16 |
| 2023-05-01 | RACE, GEOFF | President | Sale | 22,082 | $3.85 | $85015.70 |
| 2023-05-01 | LUTHRINGER, REMY | Director, CEO | Sale | 23,753 | $3.85 | $91449.05 |
| 2023-05-01 | AHLHOLM, FREDERICK W | SVP, CFO and Secretary | Sale | 3,580 | $4.48 | $16038.40 |
| 2023-04-28 | RACE, GEOFF | President | Buy | 46,987 | — | — |
| 2023-04-28 | LUTHRINGER, REMY | Director, CEO | Buy | 88,077 | — | — |
| 2023-04-28 | AHLHOLM, FREDERICK W | SVP, CFO and Secretary | Buy | 19,843 | — | — |
| 2022-12-13 | RACE, GEOFF | President | Buy | 38,000 | — | — |
| 2022-12-13 | LUTHRINGER, REMY | Director, CEO | Buy | 45,000 | — | — |
| 2022-12-13 | AHLHOLM, FREDERICK W | SVP, CFO and Secretary | Buy | 26,000 | — | — |
| 2022-06-10 | VAN, HEEK G JAN | Director | Buy | 2,500 | — | — |
| 2022-06-10 | LAGHRISSI-THODE, FOUZIA | Director | Buy | 2,500 | — | — |
| 2022-06-10 | KUPFER, DAVID | Director | Buy | 2,500 | — | — |
| 2022-06-10 | HILLEMAN, JERYL L | Director | Buy | 2,500 | — | — |
| 2022-06-10 | HASLER, HANS PETER | Director | Buy | 2,500 | — | — |
| 2022-06-10 | DOYLE, WILLIAM F | Director | Buy | 2,500 | — | — |
| 2022-02-16 | RACE, GEOFF | President | Buy | 200,000 | — | — |
| 2022-02-16 | LUTHRINGER, REMY | Director, CEO | Buy | 505,000 | — | — |
| 2022-02-16 | AHLHOLM, FREDERICK W | CFO | Buy | 180,000 | — | — |
| 2021-12-01 | KUPFER, DAVID | Director | Sale | 55,635 | $0.88 | $48958.80 |
| 2021-06-11 | VAN, HEEK G JAN | Director | Buy | 20,000 | — | — |
| 2021-06-11 | LAGHRISSI-THODE, FOUZIA | Director | Buy | 20,000 | — | — |
| 2021-06-11 | KUPFER, DAVID | Director | Buy | 20,000 | — | — |
| 2021-06-11 | HILLEMAN, JERYL L | Director | Buy | 20,000 | — | — |
| 2021-06-11 | HASLER, HANS PETER | Director | Buy | 20,000 | — | — |
| 2021-06-11 | DOYLE, WILLIAM F | Director | Buy | 40,000 | — | — |
| 2020-12-16 | REILLY, JOSEPH H. | SVP & Chief Operating Officer | Sale | 3,228 | $2.64 | $8521.92 |
| 2020-12-16 | RACE, GEOFF | EVP, CFO & CBO | Sale | 6,190 | $2.64 | $16341.60 |
| 2020-12-16 | LUTHRINGER, REMY | Director, CEO | Sale | 1,300 | $2.64 | $3432.00 |
| 2020-12-16 | AHLHOLM, FREDERICK W | SVP, Chief Accounting Officer | Sale | 1,845 | $2.64 | $4870.80 |
| 2020-12-14 | REILLY, JOSEPH H. | SVP & Chief Operating Officer | Sale | 8,750 | — | — |
| 2020-12-14 | REILLY, JOSEPH H. | SVP & Chief Operating Officer | Buy | 8,750 | — | — |
| 2020-12-14 | RACE, GEOFF | EVP, CFO & CBO | Sale | 12,500 | — | — |
| 2020-12-14 | RACE, GEOFF | EVP, CFO & CBO | Buy | 12,500 | — | — |
| 2020-12-14 | LUTHRINGER, REMY | Director, CEO | Sale | 18,750 | — | — |
| 2020-12-14 | LUTHRINGER, REMY | Director, CEO | Buy | 18,750 | — | — |
| 2020-12-14 | AHLHOLM, FREDERICK W | SVP, Chief Accounting Officer | Sale | 5,000 | — | — |
| 2020-12-14 | AHLHOLM, FREDERICK W | SVP, Chief Accounting Officer | Buy | 5,000 | — | — |
| 2020-10-13 | SMITH, DEVIN WHITTEMORE | SVP and General Counsel | Buy | 85,000 | — | — |
| 2020-10-13 | SAOUD, JAY | SVP and Head of R&D | Buy | 100,000 | — | — |
| 2020-10-13 | REILLY, JOSEPH H. | SVP & Chief Operating Officer | Buy | 85,000 | — | — |
| 2020-10-13 | RACE, GEOFF | EVP, CFO & CBO | Buy | 140,000 | — | — |
| 2020-10-13 | LUTHRINGER, REMY | Director, CEO | Buy | 200,000 | — | — |
| 2020-10-13 | DAVIDSON, MICHAEL | Chief Medical Officer | Buy | 85,000 | — | — |
| 2020-10-13 | AHLHOLM, FREDERICK W | SVP, Chief Accounting Officer | Buy | 85,000 | — | — |
| 2020-09-10 | VAN, HEEK G JAN | Director | Buy | 7,000 | $2.97 | $20790.00 |
| 2020-06-19 | SMITH, DEVIN WHITTEMORE | SVP and General Counsel | Buy | 153,531 | — | — |
| 2020-06-19 | SAOUD, JAY | SVP and Head of R&D | Buy | 236,202 | — | — |
| 2020-06-19 | RUSSELL, RICHARD E. | President | Buy | 185,025 | — | — |
| 2020-06-19 | REILLY, JOSEPH H. | SVP & Chief Operating Officer | Buy | 153,531 | — | — |
| 2020-06-19 | RACE, GEOFF | EVP, CFO & CBO | Buy | 275,568 | — | — |
| 2020-06-19 | LUTHRINGER, REMY | Director, CEO | Buy | 354,302 | — | — |
| 2020-06-19 | DAVIDSON, MICHAEL | Chief Medical Officer | Buy | 137,784 | — | — |
| 2020-06-19 | AHLHOLM, FREDERICK W | SVP, Chief Accounting Officer | Buy | 137,784 | — | — |
| 2020-06-11 | VAN, HEEK G JAN | Director | Buy | 20,000 | — | — |
| 2020-06-11 | LAGHRISSI-THODE, FOUZIA | Director | Buy | 20,000 | — | — |
| 2020-06-11 | KUPFER, DAVID | Director | Buy | 20,000 | — | — |
| 2020-06-11 | HILLEMAN, JERYL L | Director | Buy | 20,000 | — | — |
| 2020-06-11 | HASLER, HANS PETER | Director | Buy | 20,000 | — | — |
| 2020-06-11 | DOYLE, WILLIAM F | Director | Buy | 40,000 | — | — |
| 2020-05-26 | AHLHOLM, FREDERICK W | SVP, Chief Accounting Officer | Sale | 8,339 | $15.00 | $125085.00 |
| 2019-12-31 | SMITH, DEVIN WHITTEMORE | SVP and General Counsel | Buy | 41,469 | — | — |
| 2019-12-31 | SAOUD, JAY | SVP and Head of R&D | Buy | 63,798 | — | — |
| 2019-12-31 | RUSSELL, RICHARD E. | President | Buy | 49,975 | — | — |
| 2019-12-31 | REILLY, JOSEPH H. | SVP & Chief Operating Officer | Buy | 41,469 | — | — |
| 2019-12-31 | RACE, GEOFF | EVP, CFO & CBO | Buy | 74,432 | — | — |
| 2019-12-31 | LUTHRINGER, REMY | Director, CEO | Buy | 95,698 | — | — |
| 2019-12-31 | DAVIDSON, MICHAEL | Chief Medical Officer | Buy | 37,216 | — | — |
| 2019-12-31 | AHLHOLM, FREDERICK W | SVP, Chief Accounting Officer | Buy | 37,216 | — | — |
| 2019-12-17 | REILLY, JOSEPH H. | SVP & Chief Operating Officer | Sale | 2,724 | $7.10 | $19340.40 |
| 2019-12-17 | RACE, GEOFF | EVP, CFO & CBO | Sale | 5,826 | $7.10 | $41364.60 |
| 2019-12-17 | LUTHRINGER, REMY | Director, CEO | Sale | 2,412 | $7.10 | $17125.20 |
| 2019-12-17 | AHLHOLM, FREDERICK W | SVP, Chief Accounting Officer | Sale | 1,557 | $7.10 | $11054.70 |
| 2019-12-14 | REILLY, JOSEPH H. | SVP & Chief Operating Officer | Sale | 8,750 | — | — |
| 2019-12-14 | REILLY, JOSEPH H. | SVP & Chief Operating Officer | Buy | 8,750 | — | — |
Frequently asked questions
Are NERV insiders buying or selling?
Over the transactions on record, NERV insiders have been net buyers, with about $502288.33 in stock sold across 19 sales, against 1 open-market purchase.
Does insider selling at NERV mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which NERV insiders are selling the most?
Recent selling is concentrated in a few names. AHLHOLM, FREDERICK W accounts for the largest share on record, with about $157048.90 sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.